02/19/2025
4:55 PM | Kyverna Therapeutics (Issuer)
Shaw Christi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
7:00 PM | GEHCHAN NAJI (Reporting)
Kyverna Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/24/2025
7:05 PM | GEHCHAN NAJI (Reporting)
Kyverna Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
6:35 AM | Kyverna Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2024
3:57 PM | Kyverna Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/26/2024
3:40 PM | Kyverna Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
3:16 PM | Kyverna Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
6:23 AM | Kyverna Therapeutics (Subject)
Westlake BioPartners Fund I, L.P. (Filed by)
| Form SC 13G | |
10/24/2024
5:02 AM | Aktar Mert (Reporting)
Kyverna Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/24/2024
5:05 AM | Aktar Mert (Reporting)
Kyverna Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/21/2024
7:00 AM | Kyverna Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for KYTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Kyverna Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
10/10/2024
11:36 AM | JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Kyverna Therapeutics (Subject)
| Form SC 13G | |
09/18/2024
8:11 PM | Kyverna Therapeutics (Issuer)
Shaw Christi (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/18/2024
8:15 PM | Biddle Warner Weston (Reporting)
Kyverna Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/18/2024
8:16 PM | Kyverna Therapeutics (Issuer)
Shaw Christi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
8:18 PM | Biddle Warner Weston (Reporting)
Kyverna Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
7:05 AM | Kyverna Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
3:18 PM | Kyverna Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
3:11 PM | Kyverna Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/15/2024
3:11 PM | Kyverna Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
5:12 AM | Kyverna Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2024
5:56 PM | Kyverna Therapeutics (Issuer)
Walker Karen Marie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
3:33 PM | Jones Ryan Alexander (Reporting)
Kyverna Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
3:40 PM | Kyverna Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2024
3:13 PM | Kyverna Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
